Skip to main content

Table 3 Worst toxicity grade by patient during all cycles of treatment with the FOLFOX/BEVACIZUMAB combination

From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

  Grade        
  1 2 3 4
  n % n % n % n %
Neutropenia 4 7.5 10 18.9 6 11.3 2 3.8
Febrile neutropenia - - - - 1 1.9 - -
Anemia 39 73.6 5 9.4 1 1.9 - -
Thrombocytopenia 8 15.1 2 3.8 1 1.9 - -
Nausea 6 11.3 1 1.9 1 1.9 - -
Vomiting 4 7.5 2 3.8 - - - -
Diarrhea 10 18.9 7 13.2 4 7.6 - -
Mucocitis 3 5.7 - - - - - -
Constipation 9 17.0 3 5.7 - - - -
Neurotoxicity 18 33.9 9 16.9 8 15.1 - -
Alopecia 12 22.6 2 3.8 - - - -
Fatigue 13 24.5 6 11.3 - - - -